Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Kyoon Kim

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Genes, Chromosomes & Cancer|August 1, 2015
Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samplesJisun Kim, Sehwan Kim, Seyoon Ko, et al.
Cancer Research and Treatment|December 30, 2014
Nomogram for predicting breast conservation after neoadjuvant chemotherapyMin Kyoon Kim, Wonshik Han, Hyeong-Gon Moon, et al.
Journal of Breast Cancer|April 3, 2015
Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast CancerTaeryung Kim, Wonshik Han, Min Kyoon Kim, et al.
Breast Cancer Research : BCR|February 15, 2023
Diagnostic accuracy of a three-protein signature in women with suspicious breast lesions: a multicenter prospective trialEun-Shin Lee, Yumi Kim, Hee-Chul Shin, et al.
Journal of Breast Cancer|January 3, 2022
A Randomized Controlled Trial for Doing vs. Omitting Intraoperative Frozen Section Biopsy for Resection Margin Status in Selected Patients Undergoing Breast-Conserving Surgery (OFF-MAP Trial)Tae-Kyung Yoo, Young-Joon Kang, Joon Jeong, et al.
Annals of Surgical Oncology|February 6, 2015
The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean WomenJisun Kim, Wonshik Han, So-Youn Jung, et al.
Expert Opinion on Biological Therapy|April 26, 2024
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance studyMin Ho Park, Jae Hong Seo, Jung Ho Park, et al.
JAMA Surgery|August 14, 2024
Minimal Access vs Conventional Nipple-Sparing MastectomyJoo Heung Kim, Jai Min Ryu, Soong June Bae, et al.
Journal of Breast Cancer|March 3, 2024
Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority TrialJi-Jung Jung, Jong-Ho Cheun, Soo-Yeon Kim, et al.
BMC Cancer|March 12, 2014
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)Jisun Kim, Woosung Lim, Eun-Kyu Kim, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Genes, Chromosomes & Cancer|August 1, 2015
Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samplesJisun Kim, Sehwan Kim, Seyoon Ko, et al.
Cancer Research and Treatment|December 30, 2014
Nomogram for predicting breast conservation after neoadjuvant chemotherapyMin Kyoon Kim, Wonshik Han, Hyeong-Gon Moon, et al.
Journal of Breast Cancer|April 3, 2015
Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast CancerTaeryung Kim, Wonshik Han, Min Kyoon Kim, et al.
Breast Cancer Research : BCR|February 15, 2023
Diagnostic accuracy of a three-protein signature in women with suspicious breast lesions: a multicenter prospective trialEun-Shin Lee, Yumi Kim, Hee-Chul Shin, et al.
Journal of Breast Cancer|January 3, 2022
A Randomized Controlled Trial for Doing vs. Omitting Intraoperative Frozen Section Biopsy for Resection Margin Status in Selected Patients Undergoing Breast-Conserving Surgery (OFF-MAP Trial)Tae-Kyung Yoo, Young-Joon Kang, Joon Jeong, et al.
Annals of Surgical Oncology|February 6, 2015
The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean WomenJisun Kim, Wonshik Han, So-Youn Jung, et al.
Expert Opinion on Biological Therapy|April 26, 2024
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance studyMin Ho Park, Jae Hong Seo, Jung Ho Park, et al.
JAMA Surgery|August 14, 2024
Minimal Access vs Conventional Nipple-Sparing MastectomyJoo Heung Kim, Jai Min Ryu, Soong June Bae, et al.
Journal of Breast Cancer|March 3, 2024
Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority TrialJi-Jung Jung, Jong-Ho Cheun, Soo-Yeon Kim, et al.
BMC Cancer|March 12, 2014
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)Jisun Kim, Woosung Lim, Eun-Kyu Kim, et al.
Pageof 4